Selected Publications
Nelson N, Priore S, Sondermann J, Herlihy S, Watt CD: Evaluation of Positive Control Material for MGMT Promoter
Methylation Studies Journal of Molecular Diagnostics 23 (11): 1618,2021.
Gentile C, Richard-Greenblatt M, Fink J, Elkan M, Harris RM, Van Deerlin VM, Glaser L, Watt CD, Herlihy SE: A Practical Comparison of Seven Molecular SARS-CoV-2 Methods The Journal of Molecular Diagnostics 22 (11): S33,2020.
Zhang Q, Orlando EJ, Wang HY, Bogusz AM, Liu X, Lacey SF, Strauser HT, Nunez-Cruz S, Nejati R, Zhang P, Brooks S, Watt CD, Melenhorst JJ, June CH, Schuster SJ, Wasik MA: Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome Blood 136 (17): 1980-1983,2020.
Herlihy SE, Carlin A, Nasrallah NP, Watt CD and Van Deerlin VM: Evaluation of a Targeted Realtime Assay for Rapid Identification of IDH1 and IDH2 Disease-Associated Variants in Brain Tumors The Journal of Molecular Diagnostics 21 (6): 1201,2019.
Garces S, Nelson N, Watt CD, and Priore S: FLT3 Variants Near Codon 835: An Institutional Experience Comparing Rapid Restriction Digest Testing with Massively Parallel Sequencing. The Journal of Molecular Diagnostics 21 (6): 1230,2019.
McMahon C, Ferng T, Canaani J, Wang E, Morrissette J, Eastburn D, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater E, DeFilippis RA, Peretz C, McGary L, Deihimi S, Logan A, Luger S, Shah N, Carroll M, Smith C, and Perl A: Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer Discovery 9 (8): 1050-1063,2019.
Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, and Andruss BF: Analytical validation of a highly sensitive, multiplexed chronic myeloid leukemia monitoring system targeting BCR-ABL1 RNA. The Journal of Molecular Diagnostics 21 (4): 718-733,2019.
McMahon CM, Canaani J, Rea B, Sargent R, Watt CD, Morrissette JJD, Carroll M, and Perl AE: Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood Advances 3 (10): 1581-1585,2019.
Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, O’Rourke DM, and Morrissette JJD: Molecular neuropathology in practice: Clinical profiling and integrative analysis of molecular alterations in glioblastoma. Academic Pathology 6 : 2374289519848353,2019.
Nelson W, Bagley S, Watt CD, and Nasrallah M: An institutional experience with pyrosequencing for MGMT promoter methylation analysis. Modern Pathology 32 (supplement 2): 29,2019.
Academic Contact Information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia,
PA
19104